BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 31994322)

  • 1. Diagnostic challenges for a novel SH2D1A mutation associated with X-linked lymphoproliferative disease.
    Torralba-Raga L; Tesi B; Chiang SCC; Schlums H; Nordenskjöld M; Horne A; Henter JI; Meeths M; Abdelhaleem M; Weitzman S; Bryceson Y
    Pediatr Blood Cancer; 2020 Apr; 67(4):e28184. PubMed ID: 31994322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosing XLP1 in patients with hemophagocytic lymphohistiocytosis.
    Meazza R; Tuberosa C; Cetica V; Falco M; Parolini S; Grieve S; Griffiths GM; Sieni E; Marcenaro S; Micalizzi C; Montin D; Fagioli F; Moretta A; Mingari MC; Moretta L; Notarangelo LD; Bottino C; Aricò M; Pende D
    J Allergy Clin Immunol; 2014 Dec; 134(6):1381-1387.e7. PubMed ID: 24985396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. X-linked Lymphoproliferative Disease Type 1 in a Patient With the p.Gly93Asp SH2D1A Gene Mutation and Hemophagocytic Lymphohistiocytosis.
    de la Varga-Martínez R; Mora-López F; García-Cuesta D; Garrastazul-Sánchez MP; Quintero S; Rodríguez C; Sampalo A
    J Pediatr Hematol Oncol; 2017 Nov; 39(8):e483-e485. PubMed ID: 28816794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Two families of X-linked lymphoproliferative disease type 1 characterized by agammaglobulinemia].
    Li WY; Chen JS; Zhao Q; Dai RX; Wang YP; Zhao HY; Chen XM; Xue XH; Sun XY; Tang XM; Zhang Y; Ding Y; Zhao XD; Zhang ZY
    Zhonghua Er Ke Za Zhi; 2017 May; 55(5):377-382. PubMed ID: 28482391
    [No Abstract]   [Full Text] [Related]  

  • 5. X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the manifestations, management and outcome of the disease.
    Booth C; Gilmour KC; Veys P; Gennery AR; Slatter MA; Chapel H; Heath PT; Steward CG; Smith O; O'Meara A; Kerrigan H; Mahlaoui N; Cavazzana-Calvo M; Fischer A; Moshous D; Blanche S; Pachlopnik Schmid J; Latour S; de Saint-Basile G; Albert M; Notheis G; Rieber N; Strahm B; Ritterbusch H; Lankester A; Hartwig NG; Meyts I; Plebani A; Soresina A; Finocchi A; Pignata C; Cirillo E; Bonanomi S; Peters C; Kalwak K; Pasic S; Sedlacek P; Jazbec J; Kanegane H; Nichols KE; Hanson IC; Kapoor N; Haddad E; Cowan M; Choo S; Smart J; Arkwright PD; Gaspar HB
    Blood; 2011 Jan; 117(1):53-62. PubMed ID: 20926771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. X-Linked Lymphoproliferative Disease Type 1: A Clinical and Molecular Perspective.
    Panchal N; Booth C; Cannons JL; Schwartzberg PL
    Front Immunol; 2018; 9():666. PubMed ID: 29670631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus LMP1 inhibits the expression of SAP gene and upregulates Th1 cytokines in the pathogenesis of hemophagocytic syndrome.
    Chuang HC; Lay JD; Hsieh WC; Wang HC; Chang Y; Chuang SE; Su IJ
    Blood; 2005 Nov; 106(9):3090-6. PubMed ID: 16002423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new SH2D1A mutation in a female adult XLP disease with hemophagocytic lymphohistiocytosis and NK-cell leukemia.
    Liang JH; Zhu HY; Xu DM; Wang L; Wang Y; Qiao C; Wu YJ; Wang R; Li JY; Xu W
    Ann Hematol; 2019 Dec; 98(12):2829-2831. PubMed ID: 31758261
    [No Abstract]   [Full Text] [Related]  

  • 9. Case Report: Meningoencephalitis With Thrombotic Occlusive Vasculopathy in a Young EBV-Naïve Boy Is Associated With a Novel
    Steininger J; Rossmanith R; Geier CB; Leiss-Piller A; Thonhauser L; Weiss S; Hainfellner JA; Freilinger M; Schmidt WM; Eibl MM; Wolf HM
    Front Immunol; 2021; 12():747738. PubMed ID: 34987501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early and rapid detection of X-linked lymphoproliferative syndrome with SH2D1A mutations by flow cytometry.
    Zhao M; Kanegane H; Kobayashi C; Nakazawa Y; Ishii E; Kasai M; Terui K; Gocho Y; Imai K; Kiyasu J; Nonoyama S; Miyawaki T
    Cytometry B Clin Cytom; 2011 Jan; 80(1):8-13. PubMed ID: 20632414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No mutations of SAP/SH2D1A/DSHP and perforin genes in patients with Epstein-Barr virus-associated hemophagocytic syndrome in Japan.
    Ma X; Okamura A; Yosioka M; Ishiguro N; Kikuta H; Kobayashi K
    J Med Virol; 2001 Oct; 65(2):358-61. PubMed ID: 11536244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid detection of intracellular SH2D1A protein in cytotoxic lymphocytes from patients with X-linked lymphoproliferative disease and their family members.
    Tabata Y; Villanueva J; Lee SM; Zhang K; Kanegane H; Miyawaki T; Sumegi J; Filipovich AH
    Blood; 2005 Apr; 105(8):3066-71. PubMed ID: 15632210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatal hemophagocytic lymphohistiocytosis associated with Epstein-Barr virus infection in a patient with a novel mutation in the signaling lymphocytic activation molecule-associated protein.
    Halasa NB; Whitlock JA; McCurley TL; Smith JA; Zhu Q; Ochs H; Dermody TS; Crowe JE
    Clin Infect Dis; 2003 Nov; 37(10):e136-41. PubMed ID: 14583885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. X-Linked Lymphoproliferative Syndrome Presenting as Adult-Onset Multi-Infarct Dementia.
    Blackburn PR; Lin WL; Miller DA; Lorenzo-Betancor O; Edwards ES; Zimmermann MT; Farrugia LP; Freeman WD; Soto AI; Walton RL; Klee EW; Atwal PS; Abraham RS; Billadeau DD; Ross OA; Dickson DW; Meschia JF
    J Neuropathol Exp Neurol; 2019 May; 78(5):460-466. PubMed ID: 30990878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a new disease-causing mutation of SH2D1A in a family with X-linked lymphoproliferative disease.
    Erdõs M; Uzvölgyi E; Nemes Z; Török O; Rákóczi E; Went-Sümegi N; Sümegi J; Maródi L
    Hum Mutat; 2005 May; 25(5):506. PubMed ID: 15841490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a novel nonsense mutation in SH2D1A in a patient with X-linked lymphoproliferative syndrome type 1: a case report.
    Lyu X; Guo Z; Li Y; Fan R; Song Y
    BMC Med Genet; 2018 Apr; 19(1):60. PubMed ID: 29649976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe XLP Phenotype Caused by a Novel Intronic Mutation in the SH2D1A Gene.
    Tóth B; Soltész B; Gyimesi E; Csorba G; Veres Á; Lányi Á; Kovács G; Maródi L; Erdős M
    J Clin Immunol; 2015 Jan; 35(1):26-31. PubMed ID: 25491288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatal X-linked lymphoproliferative disease type 1-associated limbic encephalitis with positive anti-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antibody.
    Ochiai S; Hayakawa I; Ohashi E; Hamano S; Miyata Y; Sakuma H; Hogetsu K; Gocho Y; Ogura M; Uchiyama T; Abe Y
    Brain Dev; 2022 Oct; 44(9):630-634. PubMed ID: 35778314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of SH2D1A missense mutations identified in X-linked lymphoproliferative disease patients.
    Morra M; Simarro-Grande M; Martin M; Chen AS; Lanyi A; Silander O; Calpe S; Davis J; Pawson T; Eck MJ; Sumegi J; Engel P; Li SC; Terhorst C
    J Biol Chem; 2001 Sep; 276(39):36809-16. PubMed ID: 11477068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening the PRF1, UNC13D, STX11, SH2D1A, XIAP, and ITK gene mutations in Chinese children with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
    Zhizhuo H; Junmei X; Yuelin S; Qiang Q; Chunyan L; Zhengde X; Kunling S
    Pediatr Blood Cancer; 2012 Mar; 58(3):410-4. PubMed ID: 21674762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.